InvestorsHub Logo
Followers 4
Posts 1483
Boards Moderated 0
Alias Born 12/11/2013

Re: fred198484 post# 30531

Thursday, 10/12/2017 2:57:03 AM

Thursday, October 12, 2017 2:57:03 AM

Post# of 38634
Thank you fred,

I believe the raise will turn out a positive IF it has been made with the right subject.

"So, right now, we have a company which will likely only have sales and hopefully earnings from ANDA's between now and late 2019 when perhaps RExista will finally start generating revenues (Mackie says not until 2020). That is a long time to wait. A Rexista approval and partnership deal with Purdue or someone else would certainly help make the wait seem shorter but there are no guarantees on either front."

they have to move on with PODRAS (and the new oxy) and REGABATIN; can Odidi still think to wait for further ANDAs approvals ? can he really ?

still puzzled why putting out Q3 earnings with all the wording concerning cash needs, Seroquel ramping up or not, etc...and then the morning after PR tha new shares issuance (which was clearly ready to 12 hours before).
There is something ODD here...or just stupid ? not sure

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPCI News